Physician profile
Manojkumar D Patel
NPI 1396953469
$10,657.57
in general payments reported to CMS, 2019-2025
49 companies · $2,288 in 2025
The $2,288 reported for 2025 was more than what 78% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,352 · 2020: $1,339 · 2021: $1,001 · 2022: $1,214 · 2023: $1,739 · 2024: $1,725 · 2025: $2,288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,486 · Education: $266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,485.93 |
| Education | $266.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,918.42 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,099.42 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Genzyme Corporation | $861.53 | 2019-2025 | |
| Ani Pharmaceuticals, INC. | $527.72 | 2023-2025 | Purified Cortrophin Gel |
| Actelion Pharmaceuticals US, INC. | $464.42 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Mallinckrodt Hospital Products INC. | $449.17 | 2020-2025 | Acthar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $440.73 | 2019-2025 | Spiriva Respimat, Ofev, Stiolto Respimat |
| Grifols USA, LLC | $326.29 | 2019-2024 | Prolastin-C Liquid |
| Mylan Specialty L.P. | $323.85 | 2019-2024 | Yupelri |
| Philips North America LLC | $315.69 | 2019-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Genentech USA, INC. | $305.36 | 2019-2025 | Xolair |
| Regeneron Healthcare Solutions, INC. | $295.68 | 2019-2025 | Dupixent |
| Amgen INC. | $245.22 | 2022-2025 | Tezspire |
| Merck Sharp & Dohme LLC | $238.11 | 2021-2025 | Winrevair, Zerbaxa, Keytruda |
| Jazz Pharmaceuticals INC. | $210.34 | 2022-2025 |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $202.97 | 2021-2023 | Nuzyra |
| Takeda Pharmaceuticals U.S.A., INC. | $201.06 | 2020-2025 | Glassia |
| Baxter Healthcare | $199.65 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Volara System |
| Harmony Biosciences LLC | $190.48 | 2024-2025 | |
| Pfizer INC. | $159.47 | 2019-2024 | |
| Insmed, INC. | $155.04 | 2019-2025 | Arikayce, Brinsupri |
| Novartis Pharmaceuticals Corporation | $142.46 | 2019-2022 | |
| Abbvie INC. | $135.01 | 2021-2025 | |
| Livanova USA, INC. | $109.84 | 2023 | Lifesparc |
| Viatris Specialty LLC | $84.51 | 2025 | Yupelri |
| Electromed, INC. | $82.94 | 2021-2025 | Smartvest |
| Teva Pharmaceuticals USA, INC. | $80.49 | 2020 | |
| Pulmonx Corporation | $77.85 | 2021-2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Sanofi-Aventis U.S. LLC | $74.75 | 2022 | |
| La Jolla Pharmaceutical Company | $71.29 | 2021-2024 | Giapreza |
| Allergan, INC. | $70.44 | 2019-2020 | |
| Advanced Respiratory, INC | $64.55 | 2019-2020 | |
| Inogen, INC. | $62.37 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Vifor Pharma, INC. | $49.05 | 2024 | Zemaira |
| Axsome Therapeutics, INC. | $47.32 | 2025 | Sunosi |
| Mallinckrodt Enterprises LLC | $47.18 | 2019 | |
| Sunovion Pharmaceuticals INC. | $46.37 | 2019-2020 | |
| Circassia INC. | $41.26 | 2019-2020 | |
| Pharming Healthcare, INC. | $31.79 | 2022-2023 | Ruconest |
| Verona Pharma, INC. | $31.62 | 2025 | Ohtuvayre |
| Lilly USA, LLC | $27.95 | 2025 | Zepbound |
| Shionogi INC | $27.39 | 2024 | Fetroja |
| Stryker Corporation | $21.50 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Resmed Corp | $19.82 | 2024 | |
| Janssen Pharmaceuticals, INC | $18.46 | 2020 | |
| Gilead Sciences, INC. | $16.34 | 2021 | |
| Inspire Medical Systems, INC. | $15.22 | 2025 | Inspire |
| Masimo Corporation | $14.71 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manojkumar Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.